J V Torres
Overview
Explore the profile of J V Torres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinto-Meza A, Haro J, Palacin C, Torres J, Ochoa S, Vilagut G, et al.
Actas Esp Psiquiatr
. 2008 Jun;
35 Suppl 2:12-20.
PMID: 18264865
Introduction: Mental disorders and chronic physical conditions significantly impair health related quality of life (HRQOL). To date, there are no studies in the general population of Spain about their impact....
2.
Autonell J, Vila F, Pinto-Meza A, Vilagut G, Codony M, Almansa J, et al.
Actas Esp Psiquiatr
. 2008 Jun;
35 Suppl 2:4-11.
PMID: 18264864
Introduction: Comorbidity among mental disorders in the general population is common, affecting more than the 50 % of individuals with a lifetime mental disorder. In Spain, there are no data...
3.
Augusti P, Conterato G, Somacal S, Sobieski R, Spohr P, Torres J, et al.
Food Chem Toxicol
. 2007 Sep;
46(1):212-9.
PMID: 17881112
Reactive oxygen species are implicated as mediators of tissue damage in the acute renal failure induced by inorganic mercury. Astaxanthin (ASX), a carotenoid with potent antioxidant properties, exists naturally in...
4.
Bernal M, Haro J, Bernert S, Brugha T, de Graaf R, Bruffaerts R, et al.
J Affect Disord
. 2006 Nov;
101(1-3):27-34.
PMID: 17074395
Background: Precise knowledge of the epidemiology of suicidality provides necessary information for designing prevention programs. The aims of the present study were to investigate the prevalence and correlates of suicidal...
5.
Smith J, Torres J
Viral Immunol
. 2002 Jan;
14(4):339-48.
PMID: 11792063
A versatile DNA vaccine (pdIV3) was constructed by replacing the integrase, vif, vpx, and vpr genes of a pathogenic simian immunodeficiency virus (SIV) molecular clone with a linker containing unique...
6.
Hel Z, Nacsa J, Kelsall B, Tsai W, Letvin N, Parks R, et al.
J Virol
. 2001 Nov;
75(23):11483-95.
PMID: 11689630
The identification of several simian immunodeficiency virus mac251 (SIV(mac251)) cytotoxic T-lymphocyte epitopes recognized by CD8(+) T cells of infected rhesus macaques carrying the Mamu-A*01 molecule and the use of peptide-major...
7.
Anderson D, Carlos M, Nguyen L, Torres J
Clin Immunol
. 2001 Oct;
101(2):152-7.
PMID: 11683574
Original antigenic sin describes a phenomenon in which the antibody response elicited in an individual after a secondary viral infection reacts more strongly to the viral variant that originally infected...
8.
Gov Y, Bitler A, DellAcqua G, Torres J, Balaban N
Peptides
. 2001 Oct;
22(10):1609-20.
PMID: 11587789
Staphylococcus aureus are gram-positive bacteria that can cause serious diseases in humans and animals. S. aureus infections can be prevented by the heptapeptide RNAIII inhibiting peptide (RIP). RIP was originally...
9.
Dunn S, Torres J, Oh J, Cykert D, Barrett J
Cancer Res
. 2001 Mar;
61(4):1367-74.
PMID: 11245436
Elevated levels of urokinase plasminogen activator-1 (uPA) and the insulin-like growth factor-I receptor (IGF-IR) are associated with breast cancer recurrence and decreased survival. It is possible that activation of IGF-IR...
10.
Balaban N, Collins L, Cullor J, HUME E, Medina-Acosta E, Vieira da Motta O, et al.
Peptides
. 2000 Nov;
21(9):1301-11.
PMID: 11072116
Staphylococcus aureus causes many diseases including cellulitis, keratitis, osteomyelitis, septic arthritis and mastitis. The heptapeptide RIP has been shown to prevent cellulitis in mice, which was induced by S. aureus...